BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula
Retirement of Largest Outstanding Convertible Debt Clears Runway for High-Growth E-Commerce Rollout of a Targeted Stem Cell Platform LAS VEGAS,...
Brain
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses,...
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
ZUG, Switzerland, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The FDA Division of Neurology provided positive feedback supporting a regulatory pathway...
We The Billions Launches Personalized Cognitive Care Focused on How Each Brain Works
Speech-language pathologist Sanna Darwish says understanding how a brain works, not just what diagnosis it may carry, could reshape the...
SimpleC Brings Personalized Daily Support for Aging and Dementia Into the Home
Beginning August 1, 2026, individuals and families will be able to access SimpleC's personalized Companion platform directly for use at...
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
Ad hoc announcement pursuant to Art. 53 LR QUVIVIQ™ (daridorexant) sales reached CHF 91 million in H1 2026, up 62%...
BRAVE Providers, LLC Launches The BRAVE Method, an Organizational Training Program Addressing Vicarious Trauma and Resilience in Trauma-Exposed Organizations
Developed by trauma psychologist Jenny Hughes, PhD, the evidence-informed training gives groups, agencies, and organizations a shared framework for building...
BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform
LAS VEGAS, NV / ACCESS Newswire / July 29, 2026 / BioAdaptives, Inc. (OTCID:BDPT), a developer of natural, science-backed wellness...
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
Consolidated net revenue of € 1,410.8 million in the first half of 2026, +6.6% or +9.1% on a like-for-like basis(3)...
Healia Launches with $18M to Cut Healthcare Costs for Dual-Income Families
The company has given families nationwide access to $33 million in benefits, covering out-of-pocket costs for care from hospital stays...
NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial
SHELTON, CT / ACCESS Newswire / July 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
PreveCeutical Closes Third Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"),...
Champions Oncology Reports Record Annual Revenue of $59 Million
Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / July 27, 2026 / Champions Oncology,...
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region Allschwil,...
CogniHoney Opens Up Its 2026 Formula: What the Four-Ingredient Label Shows About Baobab Fiber and Spermidine
Cogni Honey Publishes Updated Ingredient, Serving, Label, and Safety Information for Its Current Dietary Supplement FormulaLargo, FL, July 25, 2026...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the...
Aware Recovery Care Expands Personalized Addiction Treatment with New GLP-1 Medication Option for Clinically Appropriate Clients
MIDDLETOWN, CT / ACCESS Newswire / July 22, 2026 / Aware Recovery Care, a national leader in in-home and virtual...
As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
SHELTON, CT / ACCESS Newswire / July 22, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology
Intra-operative Study with TU Munich Klinikum Rechts der Isar for First Use of ABILITY's Technology to Record Signals from the...
Natus expands access to autoSCORE AI analysis through BRAIN QUICK Software
Artificial Intelligence model added to new update of Europe's most widely used EEG software platform MIDDLETON, Wis., July 21, 2026...